Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Stepanova, M."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 62
Tytuł:
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry.
Autorzy:
Younossi ZM; Department of Medicine, Center for Liver Diseases, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Beatty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.
Yu ML; Hepatobiliary Division, Department of Medicine, Kaohsiung Medical University Hospital; Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung, Kaohsiung, Taiwan.; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
El-Kassas M; Endemic Medicine and Hepato-Gastroenterology Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
Esmat G; Endemic Medicine Department, Cairo University Hospitals, Cairo, Egypt.
Castellanos Fernández MI; Institute of Gastroenterology, University of Medical Sciences of Havana cuba, Barcelona, Cuba.
Buti M; Liver Unit Vall d'Hebron University Hospital, and CIBEREHD del Instituto Carlos III Barcelona, Barcelona, Spain.
Papatheodoridis G; Medical School of the National and Kapodistrian University of Athens, Athens, Greece, Greece.
Yilmaz Y; Institute of Gastroenterology, Marmara University, Istanbul, Turkey.; Department of Gastroenterology, School of Medicine, Marmara University, Istanbul, Turkey.
Isakov V; Gastroenterology and Hepatology at Federal Research Centre of Nutrition, Biotechnology and Food Safety, Moscow, Russia.
Duseja A; Department of Hepatology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Méndez-Sánchez N; Medica Sur Clinic and Foundation, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
Hamid S; Section of Gastroenterology, Department of Medicine, Aga Khan University, Karachi, Pakistan.
Gordon SC; Department of Gastroenterology, Henry Ford Health Systems, Detroit, Michigan, USA.
Romero-Gómez M; Digestive Diseases Department and CIBEREHD, Virgen del Rocío University Hospital. Institute of Biomedicine of Seville (HUVR/CSIC/US). University of Seville, Seville, Spain.
Chan WK; Gastroenterology and Hepatology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Ong JP; College of Medicine, University of Philippines, Manila, Philippines.
Younossi I; Center for Outcomes Research in Liver Diseases, Washington, Columbia, USA.
Lam B; Department of Medicine, Center for Liver Diseases, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Beatty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.
Ziayee M; Center for Outcomes Research in Liver Diseases, Washington, Columbia, USA.
Nader F; Center for Outcomes Research in Liver Diseases, Washington, Columbia, USA.
Racila A; Department of Medicine, Center for Liver Diseases, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.; Beatty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA.
Henry L; Center for Outcomes Research in Liver Diseases, Washington, Columbia, USA.
Stepanova M; Center for Outcomes Research in Liver Diseases, Washington, Columbia, USA.
Pokaż więcej
Corporate Authors:
Global NASH Council™
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2022 Nov; Vol. 29 (11), pp. 1015-1025. Date of Electronic Publication: 2022 Sep 07.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Hepatitis C, Chronic*/epidemiology
Antiviral Agents/therapeutic use ; Drug Therapy, Combination ; Fatigue ; Female ; Hepacivirus ; Humans ; Patient Reported Outcome Measures ; Quality of Life ; Registries ; Sofosbuvir/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units.
Autorzy:
Deshpande R; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia.
Stepanova M; Center for Outcomes Research in Liver Diseases, Washington, District of Columbia.
Golabi P; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia.
Brown K; Division of Gastroenterology, Henry Ford Hospital, Detroit, Michigan.
Younossi ZM; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia.; Center For Liver Disease, Department of Medicine, Inova Fairfax Medical Campus, Falls Church, Virginia.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2019 Nov; Vol. 26 (11), pp. 1293-1300. Date of Electronic Publication: 2019 Aug 02.
Typ publikacji:
Journal Article
MeSH Terms:
Medicare*
Patient Acceptance of Health Care*
Renal Dialysis*/methods
Renal Dialysis*/statistics & numerical data
Hepatitis C/*epidemiology
Aged ; Aged, 80 and over ; Female ; Health Resources ; Hepatitis C/mortality ; Humans ; Male ; Middle Aged ; Mortality ; Odds Ratio ; Prevalence ; Prognosis ; Retrospective Studies ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Patient-reported outcomes in patients co-infected with hepatitis C virus and human immunodeficiency virus treated with sofosbuvir and velpatasvir: The ASTRAL-5 study.
Autorzy:
Younossi ZM; Department of Medicine, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA.; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.
Stepanova M; Center for Outcomes Research, Washington, DC, USA.
Sulkowski M; John Hopkins University, Baltimore, MD, USA.
Wyles D; University of California in San Diego, San Diego, CA, USA.
Kottilil S; Division of Clinical Care and Research, Institute of Human Virology, University of Maryland, Baltimore, MD, USA.
Hunt S; Center for Outcomes Research, Washington, DC, USA.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2017 Dec; Vol. 37 (12), pp. 1796-1804. Date of Electronic Publication: 2017 May 25.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*therapeutic use
Carbamates/*therapeutic use
HIV Infections/*drug therapy
Hepatitis C/*drug therapy
Heterocyclic Compounds, 4 or More Rings/*therapeutic use
Sofosbuvir/*therapeutic use
Case-Control Studies ; Cohort Studies ; Coinfection ; Drug Combinations ; Female ; HIV Infections/complications ; Hepatitis C/complications ; Humans ; Male ; Middle Aged ; Patient Reported Outcome Measures
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor.
Autorzy:
Stepanova M; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Claude Moore Health Education and Research Building 3300 Gallows Road, Falls Church, VA, 22042, USA.; Center for Outcomes Research in Liver Diseases, Washington, DC, USA.
Sayiner M; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Claude Moore Health Education and Research Building 3300 Gallows Road, Falls Church, VA, 22042, USA.
de Avila L; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Claude Moore Health Education and Research Building 3300 Gallows Road, Falls Church, VA, 22042, USA.
Younoszai Z; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Claude Moore Health Education and Research Building 3300 Gallows Road, Falls Church, VA, 22042, USA.
Racila A; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Claude Moore Health Education and Research Building 3300 Gallows Road, Falls Church, VA, 22042, USA.
Younossi ZM; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Claude Moore Health Education and Research Building 3300 Gallows Road, Falls Church, VA, 22042, USA. .; Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA, USA. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2016 Nov 15; Vol. 16 (1), pp. 137. Date of Electronic Publication: 2016 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
Donor Selection*
Hepacivirus*
Hepatitis C/*surgery
Liver Transplantation/*mortality
Transplants/*virology
Adult ; Female ; Graft Survival ; Hepatitis C/virology ; Hepatitis C Antibodies/analysis ; Humans ; Liver/surgery ; Liver/virology ; Liver Transplantation/methods ; Male ; Middle Aged ; Registries ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Letter: effects of hepatitis C infection on the post-lung transplant mortality - authors' reply.
Autorzy:
Stepanova M; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.
Younossi Z; Center for Outcomes Research in Liver Diseases, Washington, DC, USA. .
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2016 Oct; Vol. 44 (7), pp. 768-9.
Typ publikacji:
Letter; Comment
MeSH Terms:
Hepatitis C*
Lung Transplantation*
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot study.
Autorzy:
Younossi ZM; Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA. .; Center for Outcomes Research in Liver Diseases, Washington, DC, USA. .; Betty and Guy Beatty Center for Integrated Research, Claude Moore Health Education and Research Building, 3300 Gallows Road, Falls Church, VA, 22042, USA. .
LaLuna LL; Digestive Disease Associates, Wyomissing, PA, USA.
Santoro JJ; AGA Clinical Research Associates, LLC, Egg Harbor Township, NJ, USA.
Mendes F; GastroHealth, Miami, FL, USA.
Araya V; Central Bucks Specialists, Gastroenterology, Doylestown, PA, USA.
Ravendhran N; Digestive Diseases Associates, Catonsville, MD, USA.
Pedicone L; Cantara Clinical Solutions, LLC, Morristown, NJ, USA.
Lio I; Cantara Clinical Solutions, LLC, Morristown, NJ, USA.
Nader F; Center for Outcomes Research in Liver Diseases, Washington, DC, USA.
Hunt S; Center for Outcomes Research in Liver Diseases, Washington, DC, USA.
Racila A; Center for Outcomes Research in Liver Diseases, Washington, DC, USA.
Stepanova M; Center for Outcomes Research in Liver Diseases, Washington, DC, USA.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2016 Apr 04; Vol. 16, pp. 45. Date of Electronic Publication: 2016 Apr 04.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis C/*diagnosis
Hepatitis C Antibodies/*blood
RNA, Viral/*blood
Black or African American/statistics & numerical data ; Aged ; Centers for Disease Control and Prevention, U.S. ; Depression/epidemiology ; Female ; Gastroenterology ; Hepatitis C/blood ; Hepatitis C/epidemiology ; Humans ; Male ; Mass Screening ; Middle Aged ; Pilot Projects ; Practice Guidelines as Topic ; Prevalence ; United States/epidemiology ; White People/statistics & numerical data
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Editorial: The association of hepatitis C virus infection and post-liver transplant diabetes - authors' reply.
Autorzy:
Stepanova M; Department of Medicine, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.
Younossi Z
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2015 Mar; Vol. 41 (5), pp. 489.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Diabetes Mellitus/*epidemiology
Hepatitis C/*complications
Hepatitis C/*epidemiology
Liver Transplantation/*adverse effects
Transplant Recipients/*statistics & numerical data
Female ; Humans ; Male
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients.
Autorzy:
Younossi Z; Department of Medicine, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA; Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA.
Stepanova M
Saab S
Trimble G
Mishra A
Henry L
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2015 Jan; Vol. 41 (2), pp. 209-17. Date of Electronic Publication: 2014 Nov 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus/*epidemiology
Hepatitis C/*complications
Hepatitis C/*epidemiology
Liver Transplantation/*adverse effects
Transplant Recipients/*statistics & numerical data
Female ; Hepacivirus ; Hepatitis B/complications ; Hepatitis B/epidemiology ; Humans ; Incidence ; Male ; Middle Aged ; Risk Factors ; Time Factors ; United States/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Editorial: patients' preferences and health utility assessment in those with HCV treated with sofosbuvir - stating the obvious? Authors' reply.
Autorzy:
Stepanova M; Department of Medicine, Center for Liver Disease, Inova Fairfax Hospital, Falls Church, VA, USA. Maria.Stepanova@inova.org.
Younossi Z
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2014 Nov; Vol. 40 (9), pp. 1116.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Patient Acceptance of Health Care*
Patient Preference*
Antiviral Agents/*therapeutic use
Hepatitis C/*drug therapy
Uridine Monophosphate/*analogs & derivatives
Humans
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity.
Autorzy:
Stepanova M; Center for Liver Diseases and Department of Medicine, Inova Fairfax Hospital Betty, Inova Health System, Falls Church, VA, USA.
Lam B
Younossi Y
Srishord MK
Younossi ZM
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2012 May; Vol. 19 (5), pp. 341-5. Date of Electronic Publication: 2011 Nov 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Insulin Resistance*
Diabetes Mellitus, Type 2/*epidemiology
Hepatitis C/*complications
Obesity/*complications
Adult ; Blood Glucose/analysis ; Female ; Hepatitis C Antibodies/blood ; Humans ; Male ; Middle Aged ; Prevalence ; United States/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Vietnamese community screening for hepatitis B virus and hepatitis C virus.
Autorzy:
Kallman JB; Center for Liver Diseases Outcomes Research Program, Inova Fairfax Hospital, Betty and Guy Beatty Center for Integrated Research, Falls Church, VA, USA.
Tran S
Arsalla A
Haddad D
Stepanova M
Fang Y
Wrobel VJ
Srishord M
Younossi ZM
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2011 Jan; Vol. 18 (1), pp. 70-6.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Community Health Services/*methods
Hepacivirus/*immunology
Hepatitis B/*diagnosis
Hepatitis B virus/*immunology
Hepatitis C/*diagnosis
Adult ; Emigrants and Immigrants ; Hepatitis B/epidemiology ; Hepatitis B Surface Antigens/blood ; Hepatitis B virus/isolation & purification ; Hepatitis C/epidemiology ; Hepatitis C Antibodies/blood ; Humans ; Mass Screening ; Middle Aged ; Prevalence ; Vietnam/ethnology ; Virginia/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels.
Autorzy:
Younossi, Z.M.
Elsheikh, E.
Stepanova, M.
Gerber, L.
Nader, F.
Stamm, L.M.
Brainard, D.M.
McHutchinson, J.G.
Pokaż więcej
Temat:
HEPATITIS C
HEPATITIS C treatment
APOLIPOPROTEINS
BLOOD serum analysis
CARBAMATES
GENOTYPES
PATIENTS
Źródło:
Journal of Viral Hepatitis; Dec2015, Vol. 22 Issue 12, p977-982, 6p
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C.
Autorzy:
Younossi, Z. M.
ZhENg, L.
Stepanova, M.
VENkatesan, C.
Mir, H. M.
Pokaż więcej
Temat:
HEPATITIS C
VIRAL hepatitis
ALCOHOL drinking
CARDIOVASCULAR diseases
LIVER diseases
DIAGNOSIS
Źródło:
Alimentary Pharmacology & Therapeutics; Apr2013, Vol. 37 Issue 7, p703-709, 7p, 4 Charts
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 62

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies